What causes bilateral lower eyelid and malar (cheekbone area) discoloration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bilateral Lower Eyelid and Malar Discoloration: Causes and Evaluation

Bilateral lower eyelid and malar discoloration is most commonly caused by periorbital hyperpigmentation (POH), which results from constitutional/genetic factors, vascular congestion, postinflammatory changes, or shadowing from anatomic structures, with the vascular type being most prevalent (41.8% of cases) followed by constitutional type (38.6%). 1

Primary Etiologic Categories

Constitutional/Genetic Periorbital Hyperpigmentation

  • Most common in individuals of Indian and Malay descent, presenting as bilateral symmetric darkening of the lower eyelids extending to the malar region 1
  • Results from increased melanin deposition in the epidermis and dermis, often hereditary in nature 2
  • This type shows epidermal hyperpigmentation on histopathology with increased melanocytic activity 3

Vascular Periorbital Hyperpigmentation

  • Predominant type overall (41.8%), most frequently seen in Chinese populations 1
  • Caused by excessive vascularity and periorbital edema creating a bluish-purple discoloration 2
  • The thin periorbital skin allows visualization of underlying vascular structures, creating the appearance of darkening 4

Postinflammatory Hyperpigmentation

  • Accounts for 12% of POH cases and results from prior inflammation or dermatitis 1
  • Atopic dermatitis and allergic contact dermatitis are key triggers, causing secondary hyperpigmentation in the periorbital region 2
  • Associated with chronic rubbing, scratching, or irritation from topical products 4

Dermatologic Conditions with Malar Involvement

Rosacea presents with characteristic malar rash, facial erythema, telangiectasias, papules, pustules, and prominent sebaceous glands, which can extend to the periorbital area 5

Melasma can involve the malar region in its characteristic patterns (centrofacial, malar, or mandibular distribution), though typically spares the immediate eyelid margin 3, 6

Anatomic/Structural Causes

  • Shadow effects from skin laxity and tear trough deformity account for 11.4% of cases, particularly with aging 1
  • Floppy eyelid syndrome causes upper eyelid edema but can create secondary changes affecting lower lid appearance through chronic irritation 5

Critical Diagnostic Distinctions

Inflammatory/Infectious Causes to Exclude

Allergic conjunctivitis presents with bilateral eyelid edema, conjunctival injection, and watery/mucoid discharge—but this is acute rather than chronic discoloration 7

Medication-induced keratoconjunctivitis shows bilateral conjunctival injection with contact dermatitis of eyelids (erythema and scaling), particularly with topical glaucoma medications, NSAIDs, or preservatives 5, 8

Chronic blepharitis may cause eyelid margin changes but typically presents with crusting, telangiectasias, and meibomian gland dysfunction rather than malar extension 5

Evaluation Approach

Clinical Examination Priorities

Examine the skin for rosacea features: rhinophyma, erythema, telangiectasia, papules, pustules, and hypertrophic sebaceous glands in malar areas 5

Assess pigmentation pattern: constitutional POH shows uniform bilateral darkening, vascular type has bluish hue, postinflammatory shows irregular patches 1

Wood's lamp examination differentiates epidermal (pigment enhancement) from dermal (no enhancement) or mixed types of hyperpigmentation 3

Mexameter measurement objectively quantifies the extent and severity of periorbital hyperpigmentation 1

Historical Red Flags

  • Recent medication changes (topical eye drops, systemic agents like megestrol acetate) 8
  • History of atopic dermatitis, allergic rhinitis, or chronic eye rubbing 2
  • Sun exposure patterns and use of cosmetics 3
  • Family history of similar pigmentation (constitutional type) 2

Common Pitfalls

Do not assume all bilateral periorbital darkening is benign constitutional hyperpigmentation—medication-induced causes require discontinuation of the offending agent 8

Avoid missing underlying rosacea, which requires specific management including eyelid hygiene and potential systemic therapy for ocular involvement 5

Do not overlook postinflammatory causes that may respond to treatment of the underlying dermatitis rather than depigmenting agents alone 2, 6

References

Research

Periorbital hyperpigmentation in Asians: an epidemiologic study and a proposed classification.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2011

Research

Periorbital Hyperpigmentation: A Comprehensive Review.

The Journal of clinical and aesthetic dermatology, 2016

Research

Melasma.

Advances in experimental medicine and biology, 1999

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Bilateral Eyelid Swelling Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Medication-Induced Conjunctivitis Associated with Megace (Megestrol Acetate)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.